- Research article
- Open Access
Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay
BMC Infectious Diseases volume 6, Article number: 40 (2006)
Continuous outbreaks of the highly pathogenic H5N1 avian influenza A in Asia has resulted in an urgent effort to improve current diagnostics to aid containment of the virus and lower the threat of a influenza pandemic. We report here the development of a PCR-based assay that is highly specific for the H5N1 avian influenza A virus.
A one-step reverse-transcription PCR assay was developed to detect the H5N1 avian influenza A virus. The specificity of the assay was shown by testing sub-types of influenza A virus and other viral and bacterial pathogens; and on field samples.
Validation on 145 field specimens from Vietnam and Malaysia showed that the assay was specific without cross reactivity to a number of other infuenza strains as well as human respiratory related pathogens. Detection was 100% from allantoic fluid in H5N1 positive samples, suggesting it to be a reliable sampling source for accurate detection.
The assay developed from this study indicates that the primers are specific for the H5N1 influenza virus. As shown by the field tested results, this assay would be highly useful as a diagnostic tool to help identify and control influenza epidemics.
Influenza A virus infects many animals such as humans, pigs, horses, marine mammals, and birds . In avian species, most influenza virus infections cause mild localized infections of the respiratory and intestinal tract, but highly pathogenic strains such as H5N1 cause system infections in which mortality may reach 100% . In humans, influenza viruses cause a highly contagious acute respiratory disease that resulted in epidemic and pandemic disease in humans .
Three types of influenza viruses, types A, B, and C are known and they belong to a family of single-stranded negative-sense enveloped RNA viruses called Orthomyxoviridae . The viral genome is comprised of eight RNA segments (seven in Type C). Influenza A viruses can be classified into subtypes based on antigenic differences in the two surface glycoproteins, namely, hemagglutinin (HA) and neuraminidase (NA) which are required for viral attachment and cellular release. Other major viral proteins include the nucleoprotein (NP) which is the main structural protein, membrane proteins (M1 and M2), polymerase proteins (PA, PB1 and PB2), and non-structural proteins (NS1 and NS2). Currently, sixteen subtypes of HA (H1-H16) and nine NA (N1-N9) antigenic variants are known in influenza A virus mostly related with veterinary significance, with only three subtypes circulating in humans (H1N1, H1N2, and H3N2). However, in recent years, the pathogenic H5N1 subtype of avian influenza A has been reported to cross the species barrier and infect humans as documented in Hong Kong in 1997 and 2003 [5–7]. Since late 2003, the H5N1 avian A influenza in poultry reached epidemic proportions with reports of serious outbreaks in several Asian countries including Vietnam, Thailand, South Korea, Laos, Cambodia, Indonesia, Japan and Malaysia [8, 9] that resulted in massive culling of millions of poultry which had severe economic repercussions.
As a result, H5N1 avian influenza A virus represents a potential danger to human health not only in Asia but to the world. Therefore, in addition to containment procedures, sensitive detection assays for early diagnosis are vital to lower the chances of spread and reduce the risk of development into an epidemic. Current methods employed to detect H5N1 subtypes include various polymerase chain reaction (PCR) assays [10–12, 7] and antigen tests using various fluorescence and enzyme-linked immunoassays . However, these assays are reported to be low in specificity and sensitivity, and clinically, the low sensitivity of these diagnostics may limit the usefulness for reliable detection of influenza A (H5N1) virus in humans . Therefore, there is an urgent need for improved, validated, sensitive diagnostic tests for rapid and early diagnosis. In this study, we describe the development of a nucleic acid detection test that is rapid, specific and sensitive, thus allowing greatly improved detection of the H5N1 avian influenza A virus.
Extraction of total RNA was performed following manufacturers' protocol from QIAamp Viral RNA Mini Kit (Qiagen, Germany) and TRIZOL (Invitrogen, USA) using all necessary safety precautions. The resultant RNA was dissolved in 20 μl of RNase-free water.
2 μl of RNA was used in 25 μl reaction mixtures using the One-Step reverse transcription (RT)-PCR system (Qiagen, Germany) with H5N1 specific primers (forward primer: 5'-ACTATGAAGAATTGAAACACCT-3' and reverse primer: 5'-GCAATGAAATTTCCATTACTCTC-3'). The PCR program was set as: 60°C for 1 min, 42°C for 10 min, 50°C for 30 min, and 94°C for 15 min followed by 35 cycles of 94°C for 30 sec, 50°C for 30 sec, and 72°C for 1 min and lastly followed by 72°C for 10 min. The size of this PCR product was 456 bp and was resolved in 1.2 % agarose gels. PCR products were sequenced directly to confirm the identity of the products.
Results and Discussion
Establishment of a new H5N1 PCR primer set
Primers were designed at the conserved regions of the viral HA gene which may be less likely to be affected by mutational changes. This allows the detection of a broad range of isolates and variants of the H5N1 subtype. The performance of the primers was first assessed in gel-based assays using in vitro-transcribed RNA generated by the T7 RiboMax Express in vitro transcription system (Promega, USA). The concentration of purified transcribed RNA was measured by RiboGreen RNA quantitation reagent (Invitrogen, USA) and serial dilutions of in vitro-transcribed RNA were prepared in duplicate. A single one-step RT-PCR was done using 2 μl of RNA in a thermal cycler as described in Methods, and products were analyzed on agarose gels. Non-template controls were included. The sensitivity of the assay was found to be less than 1 × 103 copies and was able to specifically detect H5N1 RNA (Fig. 1A, lanes 2 to 11).
Specific detection of H5N1 avian influenza A
To establish the specificity of the assays for H5N1 subtype detection, we then tested the primers on several known strains of influenza A viruses derived from avian sources (H3N8, H5N3, H7N3 and H9N2). Non-influenza viruses such as Newcastle disease virus (NDV) were also included as controls (Fig. 1B). Thirteen of other known human respiratory diseases caused by viruses and bacteria were also included (Fig. 1A, lanes 12 to 17, and Table 1) as controls. Results showed that detection was specific to H5N1 only (Fig. 1A and 1B). As the number of actual human avian influenza virus infected cases are extremely sparse during this study, the inclusion of a panel of known human samples that do not contain H5N1 virus derived from patients exhibiting "flu"-like symptoms are very helpful in demonstrating the non cross-reactive nature of these primers. In an effort to further investigate the specificity of this set of primers, a panel of avian and human subtypes (H1 to H16) of Influenza A virus was screened. Results showed that there was reactivity only against the H5 subtypes with this primer set and no reactivity against the other subtypes (Fig. 2A, lanes 2 to 19). To ensure that the RNA from these subtypes were not degraded, the matrix gene from these samples were amplified in parallel. As expected, the 978 bp product was amplified for all the subtypes tested (Fig. 2B, lanes 22 to 36). A total of 145 field samples comprising of known and suspect cases from chickens, ducks and muscovies isolated from Vietnam and Malaysia during the 2004 to 2005 outbreak were tested for H5N1 RNA (Table 2). Samples ranged from homogenized pooled organs and tissues, allantoic fluid, cloacal and tracheal swabs. All yielded positive results with 100% positive detection for allantoic fluid, 67% for cloacal and tracheal swab, and 86% for homogenized pooled tissue and organs (Table 2) verifying the sensitivity of this RT-PCR assay. Viral culture isolation methods performed in eggs were used as confirmatory tests for all positive samples (Table 2). This variation in detection could be due to the different efficiencies in viral RNA recovery from the different samples, with allantoic fluid fractions having the highest efficiency for H5N1 RNA recovery and detection among the samples (Table 2). Optimizing the extraction protocols may also improve the RNA recovery from other tissues.
In a separate study, the sensitivity of this H5N1 primer set was also evaluated against the currently recommended World Health Organization (WHO) H5 primer set. Three different strains were used – one human archived RNA (Human 3028, from the Vietnam 2004 outbreak) and two freshly extracted avian strains (Avian 933 and Avian 949B). A RNA dilution series was done on the three samples from 10-1 to 10-8 (Fig. 3A, lanes 2 to 11 and lanes 15 to 32), and in all the three strains, the H5N1 primer set described here gave 1 to 2 logs better performance when compared to the recommended WHO primer set (Fig. 3A, Table 3), indicating that this primer set performs well and consistent. In addition, five positive samples from the Vietnam set were also then tested in parallel with another current H5 primer set and results showed that the H5N1 primers described here detected five out of five positive H5N1 samples while the other primer set only managed to detect three out of five (Fig. 3B), indicating that the H5N1 primers described here are more sensitive and could detect weak positive samples with lower viral load.
In conclusion, we have reported an efficient, specific and sensitive assay that has been evaluated on field specimens to be able to detect a wide variety of H5N1 influenza virus isolates. Accurate and sensitive detection of viral RNA is also strongly influenced by the sample type. The rapid one-step single tube reaction described here not only reduce the detection time but also lowers the risk of cross-contamination which has a higher probability in two-steps RT-PCR methods. This cost effective gel-based system has a lower limit of detection in the picogram range which is equivalent to 1 × 103 copies, and is designed to cater for use in the field in regions where real-time PCR platform and equipments may not be available. Clearly, the results would be further strengthened with the inclusion of more known H5N1 influenza in archived samples from humans, but the availability of human samples are difficult due to the low number of human infections at this point. However, observations from this study strongly suggest that the primers are specific for H5N1 which can be very useful for the early detection and monitoring of avian influenza outbreaks.
Nicholson KG, Wood JM, Zambon M: Influenza. Lancet. 2005, 362: 1733-1745. 10.1016/S0140-6736(03)14854-4.
Zeitlin GA, Maslow MJ: Avian influenza. Curr Infect Dis Rep. 2005, 7: 193-199.
Cox NJ, Subbarao K: Influenza. Lancet. 1999, 354: 1277-1282. 10.1016/S0140-6736(99)01241-6.
Swayne DE, Suarez DL: Highly pathogenic avian influenza. Rev Sci Tech. 2000, 19: 463-482.
Chan PK: Outbreak of avian influenza A (H5N1) virus infection in Hong Kong in 1997. Clin Infect Dis. 2002, 34 (Suppl 2): S58-64. 10.1086/338820.
Peiris JSM, Yu WC, Leung CW, Cheung CY, Ng NF, Nicholls JM, Ng TK, Chan KH, Lai ST, Lim WL, Yuen YY, Guan Y: Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet. 2004, 363: 617-619. 10.1016/S0140-6736(04)15595-5.
Yuen KY, Chan PK, Peiris JSM, Tsang DN, Que TL, Shortridge KF, Cheung PT, To WK, Ho ET, Sung R, Cheng AF: Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet. 1998, 351: 467-471. 10.1016/S0140-6736(98)01182-9.
Centers for Disease Control and Prevention (CDC): Cases of influenza A (H5N1) – Thailand, 2004. Morb Mortal Wkly Rep. 2004, 53: 100-3.
Hien TT, Liem NT, Dung NT, San LT, Mai PP, Chau NV, Suu PT, Dong VC, Mai LTQ, Thi NT, Khoa DB, Phat LP, Troung NT, Long HT, Giang LT, Tho ND, Tien NTK, San LH, Tuan LV, Dolecek C, Thanh TT, Jong M, Schultsz C, Cheng P, Lim W, Horby P, Farrar J: Avian Influenza A (H5N1) in 10 patients in Vietnam. N Engl J Med. 2004, 350: 1179-1188. 10.1056/NEJMoa040419.
Lau L, Banks J, Aherne R, Brown IH, Dillon N, Collins RA, Chan K, Fung YW, Xing J, Yu ACH: Nucleic acid sequence-based amplification methods to detect avian influenza virus. Biochem Biophys Res Comm. 2003, 313: 336-342. 10.1016/j.bbrc.2003.11.131.
Lee M, Chang P, Shien J, Cheng M, Shieh HK: Identification and subtyping of avian influenza viruses by reverse transcription-PCR. J Virol Methods. 2001, 97: 13-32. 10.1016/S0166-0934(01)00301-9.
Payungporn S, Phakdeewirot P, Chutinimitkul S, Theamboonlers A, Keawcharoen J, Oraveerakul K, Amonsin A, Poovorawan Y: Single-step multiplex reverse transcription-polymerase chain reaction (RT-PCR) for influenza A virus subtype H5N1 detection. Viral Immunol. 2004, 17: 588-593. 10.1089/vim.2004.17.588.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-2334/6/40/prepub
We thank Jer-Ming Chia, Martin L. Hibberd, Christopher W. Wong and Jian-Jun Liu (Genome Institute of Singapore), No-Na Yeoh, Geok-Huai Ong and Rafidah Ahmad Johari (Veterinary Research Institute, Malaysia), Fook-Kheong Ng, Chee-Wee Lim and Wai-Kwan Wong (Central Veterinary Laboratory, Agri-Food and Veterinary Authority of Singapore), and Kian-Leong Ong and Woon-Hsi Chin (Veredus Laboratories Singapore) for their contributions.
The author(s) declare that they have no competing interests.
LFPN, IB, RSPT, ECR conceived the study, its design and coordination, and results analysis. TN, SMN, LVA, SG, HK, TLT and SSH carried out the experiments and analysis. LFPN and ECR drafted the manuscript.
About this article
Cite this article
Ng, L.F., Barr, I., Nguyen, T. et al. Specific detection of H5N1 avian influenza A virus in field specimens by a one-step RT-PCR assay. BMC Infect Dis 6, 40 (2006). https://doi.org/10.1186/1471-2334-6-40
- Avian Influenza
- Newcastle Disease Virus
- Allantoic Fluid
- H5N1 Subtype